EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication

Savannah McKenna, Kwang Il Jung, Jennifer J Wolf, Young-Jin Seo, Bumsuk Hahm

Virology · 2025

DOI: 10.1016/j.virol.2024.110367 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Virology, 2025. Verfasst von Savannah McKenna und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Surgery & Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, 65212, USA. Hauptthemen laut MEDLINE: Virus Replication, Sphingolipids, Influenza, Human, Orthomyxoviridae. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH NIAID, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sphingolipid network is sustained principally by the balance of bioactive sphingolipid molecules and their regulation by sphingolipid-metabolizing enzymes. The components in the lipid system display key functions in numerous cellular and disease conditions including virus infections. During the COVID-19 pandemic, there was a fruitful effort to use an inhibitor that blocks the activity of sphingosine kinase (SphK) 2 to cure the devastating disease. Support for the inhibitor came from pre-clinical research on influenza where the inhibitor demonstrated effective protection of mice from influenza-induced morbidity and mortality. This highlights the importance of basic and translational research on the sphingolipid system for improving human health. Multiple sphingolipid-metabolizing enzymes have been reported to regulate influenza virus replication and propagation. In this review, the emphasis is placed on the roles of these enzymes that impact influenza virus life cycle and the conceivable mechanisms for the interplay between influenza virus and the sphingolipid pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus ReplicationSphingolipidsInfluenza, HumanOrthomyxoviridaeHumansAnimalsPhosphotransferases (Alcohol Group Acceptor)MiceCOVID-19SARS-CoV-2Sphingosine Kinase

Stichwörter der Autor:innen

COVID-19Influenza virusS1P lyaseSphingolipidSphingomyelinaseSphingosine kinase

Substanzen

SphingolipidsPhosphotransferases (Alcohol Group Acceptor)Sphingosine Kinase

Autor:innen und Institutionen

  • Departments of Surgery & Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, 65212, USA.
  • Department of Life Science, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul, 06974, Republic of Korea. Electronic address: yjseo@cau.ac.kr.
  • Departments of Surgery & Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, 65212, USA. Electronic address: hahmb@health.missouri.edu.

Förderung

  • NIAID NIH HHS
  • NIH NIAID
  • National Research Foundation of Korea
  • National Institutes of Health

Zitieren

APA

McKenna, S., Jung, K. I., Wolf, J. J., Seo, Y. J., & Hahm, B. (2025). Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication. Virology. https://doi.org/10.1016/j.virol.2024.110367

Vancouver

McKenna S, Jung KI, Wolf JJ, Seo YJ, Hahm B. Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication. Virology. 2025. doi:10.1016/j.virol.2024.110367

BibTeX
@article{McKenna2025,
  author = {McKenna, Savannah and Jung, Kwang Il and Wolf, Jennifer J and Seo, Young-Jin and Hahm, Bumsuk},
  title = {Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication},
  journal = {Virology},
  year = {2025},
  doi = {10.1016/j.virol.2024.110367}
}
Kostenlos starten →